Lu D Y, Lu T R, Xu B
Department of Cancer Pharmacology, Shanghai University, Shanghai 200444, China
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
Anticancer Agents Med Chem. 2018;18(14):1952-1961. doi: 10.2174/1871520618666180911113141.
The article entitled “Aberrant Sialylation in Cancer Pathology and Metastasis, a Putative Drug Target Candidate”, by Lu D.Y., Lu T.R., Xu B., Varki A., Huang M., Zhu H., Shen Y., Yarla N.S., has been retracted on the request of the co-authors Dr. Ajit Varki, Ming Huang, Hong Zhu and Ying Shen available at: Anticancer Agents Med Chem. 2018; 18(14): 1952-1961. http://www.eurekaselect.com/165282. The Corresponding Author Dr. Da-Yong Lu has included the name of the co-author Dr. Ajit Varki, Dr. Nagendra Yarla, Ming Huang, Hong Zhu and Ying Shen without their consent and the manuscript has been published in the journal Anti-Cancer Agents in Medicinal Chemistry (ACAMC). Kindly see Bentham Science Policy on Article retraction at the link given below: https://benthamscience.com/journals/anti-cancer-agents-in-medicinal-chemistry/editorial-policies/). Submission of a manuscript to the respective journals implies that all authors have read and agreed to the content of the Copyright Letter or the Terms and Conditions. As such this article represents a severe abuse of the scientific publishing system. Bentham Science Publishers takes a very strong view on this matter and apologizes to the readers of the journal for any inconvenience this may cause.
由陆大永、陆天荣、徐斌、阿吉特·瓦尔基、黄明、朱宏、沈莹、纳根德拉·亚拉撰写的题为《癌症病理学与转移中的异常唾液酸化：一种潜在的药物靶点候选物》的文章，应共同作者阿吉特·瓦尔基博士、黄明博士、朱宏博士和沈莹博士的要求已被撤回，文章原发表于《抗癌药物与医药化学》。2018年；18(14): 1952 - 1961。http://www.eurekaselect.com/165282。通讯作者陆大永博士未经共同作者阿吉特·瓦尔基博士、纳根德拉·亚拉博士、黄明博士、朱宏博士和沈莹博士同意就将他们的名字列入其中，且该稿件已发表在《药用化学中的抗癌药物》（ACAMC）期刊上。请查看本瑟姆科学出版社关于文章撤回的政策，链接如下：https://benthamscience.com/journals/anti-cancer-agents-in-medicinal-chemistry/editorial-policies/）。向各期刊提交稿件意味着所有作者已阅读并同意版权信函或条款与条件的内容。因此，本文严重滥用了科学出版系统。本瑟姆科学出版社对此事持非常严肃的态度，并就可能给该期刊读者带来的不便表示歉意。
